Latest News
Organogenesis Holdings Inc.
- Organogenesis Holdings, Inc. Class A Estimates – LS:A2PA31
- Organogenesis stock: Organogenesis published PREPARE results. November 5 tests Organogenesis stock
- Spatial multi-omic atlas profiles early organogenesis of a Carnegie stage 12 human embryo
- Organogenesis Announces Publication Of Peer-Reviewed Prepare Trial Results
- Organogenesis Announces Publication of Peer-Reviewed PREPARE Trial Results Demonstrating Clinical Benefit of PuraPly®AM for Hard-to-Heal Diabetic Foot Ulcers
- Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026
- Organogenesis Holdings Inc. to Report Third Quarter 2026 Financial Results on November 5
- Organogenesis to report Q3 FY2026 results on No...
- Organogenesis announces publication of diabetic foot ulcer trial
- DNA Typewriter, PEtracer Map Mouse Development Through Organogenesis
- Organogenesis Holdings stock falls 2.13 percent as Q2 revenue drops sharply
- How Plants Rewind Their Cells: The Molecular Secrets of De Novo Organogenesis
Headlines from the last 30 days, linking to the original publishers. See all market news →